Trial Profile
A prospective study of bivalirudin in acute coronary syndrome during percutaneous intervention
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2017
Price :
$35
*
At a glance
- Drugs Bivalirudin (Primary) ; Heparin
- Indications Acute coronary syndromes
- Focus Adverse reactions
- Acronyms CARTAGOMAX
- 25 Feb 2016 New trial record